AIMSS Research

Please join us at Annual AIMSS Research Symposium: 16th Oct 2023(Monday)- 3 to 5pm AEST,
Theme- Emerging Frontiers in Musculoskeletal Science.
Date/Venue: 16th Oct 2023, 3 - 5pm AEDT, 1st Floor Auditorium + Zoom Webinar
This webinar is a public event. All who register can join the webinar to know more about latest research and clinical translation of research in to support healthy bone, muscle, joints and ageing.
Please register at Zoom webinar link below. (event is on 16th Oct, 3 to 5pm AEDT- Australian Eastern Daylight Saving Time)
https://westernhealth.zoom.us/.../WN_jkmOZegFSgKmQhvUde_elg

Please join us. Event is open to all. Annual AIMSS Research Symposium: 24th Oct 2022- 3 to 6pm AEST, AIMSS celebrating 10 years!
Theme- Musculoskeletal research and women’s health
Date/Venue: 24th Oct 2022, 3 - 6pm AEDT, 1st Floor Auditorium + Zoom Webinar
Topic: "Real-world patterns of long-term bisphosphonate use and comparative fracture risk of osteoporosis drug holidays"
Please register at Zoom webinar link below.

Video Conferencing, Web Conferencing, Webinars, Screen Sharing Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile, desktop, and room systems. Zoom Rooms is the original software-based conference room solution used around the world in board, confer...

AIMSS Research Annual Symposium - 3pm 24th Oct 2022 AEDT ( Australian Eastern Daylight Time, Melbourne) https://aimss.org.au/events/aimss-research-symposium-2022/
Open to all researchers and all other interested medical professionals, allied health professionals and all others around the world. Please join us. Registration is a must for the zoom webinar.

Professor Gustavo Duque, our Director of AIMSS Research and the Chair of Medicine at Western Health – a world leader in ageing and musculoskeletal research, is the current President Elect of the ANZBMS. This is a great recognition of Professor Gustavo’s research leadership and also brings in valuable opportunities to increase the impact and presence of AIMSS in the Society. AIMSS Research celebrates the 10 years of service to research community and public this year (2012-2022). For more information on AIMSS please visit www.aimss.org.au.

[The Australian and New Zealand Bone and Mineral Society (ANZBMS) is a highly esteemed organisation in the musculoskeletal field in Australia and New Zealand and is recognised worldwide for its research. The Society brings together clinical and experimental scientists and physicians actively involved in the study of bone and mineral metabolism. ANZBMS web site-https://www.anzbms.org.au/office-bearers-and-council.asp].

AIMSS next seminar for research, medical,/clinical & allied health communities is scheduled on 7th June 2022 from 11am. Please join us.

Date/time:7th June 2022, 11am AEST
Speaker/Presenter: Prof Naji Abumrad MD, FACS
Delivery: Zoom Webinar, registration required.
https://unimelb.zoom.us/webinar/register/WN_hud4-KagRduTnJH9IeTkBg
“An attempt at treating sarcopenia. Lessons from the patient to the lab, and back to clinical use.”
This seminar is open to all interested researchers, professionals and public around the world. Please note registration is required to access the webinar on Zoom.

Prof Naji Abumrad MD, FACS is a world-renowned leader in the medical industry with over four decades of experience as a scientist and a surgeon. He is the Professor of Surgery, Chair of Emeritus and Vice Chair for mentoring section of Surgical Sciences at Vanderbilt University. In 2014, he was elected to the American Association of the Advancement of Science. He is also the Chair of TSI Group LTD’s Scientific Advisory Board.
Dr Abumrad is the co-inventor of HMB (Hydroxy- β-methyl- butyrate), a nutraceutical that supports healthy muscle mass and normal muscle function, both of which change with age. Dr. Abumrad also collaborated with the founders of HobamineTM focusing on the health benefits they bring related to aging, resulting in several issued patents. 2-HOBA is a compound extracted from Himalayan Tartary Buckwheat that contributes to the protection of DNA from free radical damage. It supports general cell health and acts as a scavenger for reactive carbonyl species that are caused as a secondary process to oxidative stress in human cells.
Prof Naji Abumrad focuses on his experience on treating sarcopenia patients on this seminar.

The Australian Institute for Musculoskeletal Science (AIMSS) Fracture Care and Prevention Program at Western Health (Sunshine, Footscray and Williamstown Hospitals) has been awarded Gold Star accreditation from the International Osteoporosis Foundation (IOF) – the leading global organisation in the field.

AIMSS runs in collaboration with the aged care, endocrinology, allied health, anaesthesia, emergency and orthopaedics units at Western Health. Moe info and reference from University of Melbourne : https://about.unimelb.edu.au/news-resources/awards-and-achievements/awards-and-prizes/gold-star-for-musculoskeletal-health-at-western

AIMSS celebrates 10 years of service this year(2022)!. Looking forward to add more services, bring in benefits from world class research translation, and ways of creating awareness on musculoskeletal science. Best wishes to our clients, research community and public who have been supporting us throughout last 10 years.

Victoria government Health Victoria news ( Dec 2024) about our local Falls and Fracture Prevention Program at Western Health and AIMSS: http://www3.health.vic.gov.au/healthvictoria/dec21/falls.htm

AIMSS Research is a cutting-edge research partnership that pioneers new world-leading approaches to preventing and treating musculoskeletal diseases. For more information please visit www.aimss.org.au .

Health Victoria News - Department of Health Victoria Australia The Department of Health Newsletter, Victoria, Australia, Victorian Government Health Information Website. Health.vic.gov.au is a gateway to information relating to the provision of health services in Victoria. The pages in this Website are developed and managed by the Department of Health, Victoria...

In addition to clinical research conducted by AIMSS, our AIMSS Falls and Fracture Clinic provides comprehensive assessments of a patient’s risk of falls and fractures. For more information, please visit
https://aimss.org.au/services/clinical-assessment/
Our assessments are designed to prevent fall injuries and fractures which affect:
Older Australians – 1 in 2 women and 1 in 3 men over 60 will have an osteoporotic fracture in Australia
Repeat fractures – Approximately 50% of people with one fracture due to osteoporosis will have another.
Hospital admissions – In Australia, a preventable injury-related hospitalisation for osteoporotic fractures will occur every 8 minutes.
Referrals need to be organised by a General Practitioner (GP) who need to: Assess eligibility for the Clinic based on the criteria outlined in the Falls & Fracture Clinic Referral Form from the web site above.

The Australian Institute of Musculoskeletal Science (AIMSS) is a collaborative institute for translational research into musculoskeletal diseases.

We aim to improve the health and wellbeing of the communities in which we live and work through innovative and integrative musculoskeletal research and advocacy. Our mission is to undertake focused, high quality, innovative research; foster collaborations with the research and general community; and promote healthy and active living in the communities we serve.

AIMSS unites clinicians, epidemiologists and biomedical researchers from The University of Melbourne, Western Health, and the Victoria University, bringing researchers closer to the health system and to better influence healthcare delivery based on research.

AIMSS Research updated their phone number.